# Comirnaty on The No Agenda Show

Comirnaty comes up in 11 chapters across 10 episodes of The No Agenda Show, from March 2021 to May 2023.

- **Chapters:** 11
- **Episodes:** 10
- **Discussed:** March 2021 – May 2023
- **Related topics:** [Pfizer](https://search.noagendashow.net/topic/pfizer.md), [Fda](https://search.noagendashow.net/topic/fda.md), [Biontech](https://search.noagendashow.net/topic/biontech.md), [Emergency Use Authorization](https://search.noagendashow.net/topic/emergency-use-authorization.md), [Department Of Defense](https://search.noagendashow.net/topic/department-of-defense.md), [Thomas Massie](https://search.noagendashow.net/topic/thomas-massie.md), [5g](https://search.noagendashow.net/topic/5g.md), [Anthony Fauci](https://search.noagendashow.net/topic/anthony-fauci.md), [Branding](https://search.noagendashow.net/topic/branding.md), [Cdc](https://search.noagendashow.net/topic/cdc.md)

## Chapters 1–11 of 11

### FDA Approval Confusion and Comirnaty vs. Pfizer-BioNTech

- **Episode:** [1392: TRANSNOODLE](https://search.noagendashow.net/episode/1392-transnoodle.md)
- **Published:** 2023-05-22
- **Time:** 50:08–54:09
- **Transcript:** https://search.noagendashow.net/episode/1392-transnoodle/chapter/fda-approval-confusion-and-comirnaty-vs-pfizer-biontech.md

The hosts debate the legal distinction between the FDA-approved Comirnaty vaccine and the Pfizer-BioNTech vaccine currently distributed under Emergency Use Authorization. They suggest the lack of full approval for the widely available version provides "plausible deniability" for manufacturers regarding liability.

Keywords: [fda](https://search.noagendashow.net/topic/fda.md), [comirnaty](https://search.noagendashow.net/topic/comirnaty.md), [pfizer](https://search.noagendashow.net/topic/pfizer.md), [emergency use](https://search.noagendashow.net/topic/emergency-use.md), [eula](https://search.noagendashow.net/topic/eula.md)

### Comirnaty Advertisements, Pediatric Vaccines, FDA Approval

- **Episode:** [1481: Injectables](https://search.noagendashow.net/episode/1481-injectables.md)
- **Published:** 2022-08-28
- **Time:** 58:01–1:00:21
- **Transcript:** https://search.noagendashow.net/episode/1481-injectables/chapter/comirnaty-advertisements-pediatric-vaccines-fda-approval.md

The hosts discuss the emergence of television advertisements for Comirnaty, the FDA-approved version of the Pfizer-BioNTech vaccine. They note the ads specifically target teenagers and children, and they mock the extensive list of side effects required in the commercial's fine print.

Keywords: [comirnaty](https://search.noagendashow.net/topic/comirnaty.md), [pfizer](https://search.noagendashow.net/topic/pfizer.md), [fda approval](https://search.noagendashow.net/topic/fda-approval.md), [pediatric vaccine](https://search.noagendashow.net/topic/pediatric-vaccine.md), [pharmaceutical ads](https://search.noagendashow.net/topic/pharmaceutical-ads.md), [side effects](https://search.noagendashow.net/topic/side-effects.md)

### Thomas Massie, Military Vaccine Mandate Legality

- **Episode:** [1474: Heart Dart](https://search.noagendashow.net/episode/1474-heart-dart.md)
- **Published:** 2022-08-04
- **Time:** 1:15:17–1:19:26
- **Transcript:** https://search.noagendashow.net/episode/1474-heart-dart/chapter/thomas-massie-military-vaccine-mandate-legality.md

Representative Thomas Massie, an MIT-educated engineer, challenged the legality of military vaccine mandates during a congressional markup. Massie argued that the military has not administered the FDA-approved "Comirnaty" version of the vaccine, instead using the Emergency Use Authorization (EUA) version. He contends that discharging service members based on these mandates is a violation of federal law.

Keywords: [thomas massie](https://search.noagendashow.net/topic/thomas-massie.md), [mit](https://search.noagendashow.net/topic/mit.md), [military](https://search.noagendashow.net/topic/military.md), [vaccine mandate](https://search.noagendashow.net/topic/vaccine-mandate.md), [comirnaty](https://search.noagendashow.net/topic/comirnaty.md)

### Military Vaccine Bait and Switch, Congressional Debate

- **Episode:** [1474: Heart Dart](https://search.noagendashow.net/episode/1474-heart-dart.md)
- **Published:** 2022-08-04
- **Time:** 1:20:57–1:25:20
- **Transcript:** https://search.noagendashow.net/episode/1474-heart-dart/chapter/military-vaccine-bait-and-switch-congressional-debate.md

Congressional members debated whether the Department of Defense engaged in a "bait and switch" by requiring vaccines that were not the specific FDA-approved doses. Representative Thomas Massie and others argued that the Secretary of Defense's mandate was illegal because the approved labels were not available to troops. The discussion also touched on the disproven notion that the vaccines prevent the spread of the virus.

Keywords: [thomas massie](https://search.noagendashow.net/topic/thomas-massie.md), [department of defense](https://search.noagendashow.net/topic/department-of-defense.md), [fda](https://search.noagendashow.net/topic/fda.md), [comirnaty](https://search.noagendashow.net/topic/comirnaty.md), spikevax

### Anthony Fauci, Masking and Booster Updates

- **Episode:** [1469: The Nurge](https://search.noagendashow.net/episode/1469-the-nurge.md)
- **Published:** 2022-07-17
- **Time:** 1:31:25–1:35:52
- **Transcript:** https://search.noagendashow.net/episode/1469-the-nurge/chapter/anthony-fauci-masking-and-booster-updates.md

Dr. Anthony Fauci appeared on CNN to recommend indoor masking in "orange" zones due to high infection dynamics. He also confirmed that the FDA is actively considering a second booster shot for Americans under the age of 50. Questions remain regarding why the Pfizer vaccine continues to operate under Emergency Use Authorization rather than full approval.

Keywords: [anthony fauci](https://search.noagendashow.net/topic/anthony-fauci.md), [cdc](https://search.noagendashow.net/topic/cdc.md), [fda](https://search.noagendashow.net/topic/fda.md), [mask mandates](https://search.noagendashow.net/topic/mask-mandates.md), [comirnaty](https://search.noagendashow.net/topic/comirnaty.md)

### Comirnaty Licensing, Pfizer Risk Management, and Military Trials

- **Episode:** [1422: Honk Honk](https://search.noagendashow.net/episode/1422-honk-honk.md)
- **Published:** 2022-02-03
- **Time:** 42:15–45:32
- **Transcript:** https://search.noagendashow.net/episode/1422-honk-honk/chapter/comirnaty-licensing-pfizer-risk-management-and-military-trials.md

The Department of Defense is accused of using service members as a giant study group for mRNA vaccines under a 158-page Risk Management Plan. The discussion focuses on the legal distinction between the FDA-approved Comirnaty and the Emergency Use Authorization (EUA) versions actually being administered. The hosts highlight the withdrawal of the BLA license on the same day it was granted.

Keywords: [comirnaty](https://search.noagendashow.net/topic/comirnaty.md), [pfizer](https://search.noagendashow.net/topic/pfizer.md), [fda](https://search.noagendashow.net/topic/fda.md), bla license, [risk management](https://search.noagendashow.net/topic/risk-management.md), [department of defense](https://search.noagendashow.net/topic/department-of-defense.md)

### Pfizer, Comirnaty Rebranding and Market Competition

- **Episode:** [1405: No Shields, No Deals](https://search.noagendashow.net/episode/1405-no-shields-no-deals.md)
- **Published:** 2021-12-06
- **Time:** 1:05:15–1:08:20
- **Transcript:** https://search.noagendashow.net/episode/1405-no-shields-no-deals/chapter/pfizer-comirnaty-rebranding-and-market-competition.md

A whistleblower report from the Pfizer supply chain reveals that the company is retiring the "purple cap" BioNTech vaccine in favor of the "gray cap" Comirnaty. This transition from Emergency Use Authorization (EUA) to a licensed product is seen as a move to clear inventory and potentially block competitors like Moderna and Janssen, who rely on EUA status. The move also paves the way for the approval of Pfizer's therapeutic pill, Paxlovid.

Keywords: [pfizer](https://search.noagendashow.net/topic/pfizer.md), [comirnaty](https://search.noagendashow.net/topic/comirnaty.md), [biontech](https://search.noagendashow.net/topic/biontech.md), [paxlovid](https://search.noagendashow.net/topic/paxlovid.md), [emergency use authorization](https://search.noagendashow.net/topic/emergency-use-authorization.md)

### FDA Vaccine Labeling and Legal Distinction Debate

- **Episode:** [1393: Space Wake](https://search.noagendashow.net/episode/1393-space-wake.md)
- **Published:** 2021-10-24
- **Time:** 2:04:35–2:11:05
- **Transcript:** https://search.noagendashow.net/episode/1393-space-wake/chapter/fda-vaccine-labeling-and-legal-distinction-debate.md

The hosts examine an FDA footnote stating that while the licensed Pfizer vaccine (Comirnaty) and the Emergency Use Authorization (EUA) version have the same formulation, they are "legally distinct." This leads to a discussion about the potential reasons for this distinction, ranging from liability protections to more conspiratorial theories about "self-assembling nanotechnology." They emphasize the confusing nature of the government's official documentation regarding vaccine approval.

Keywords: [fda](https://search.noagendashow.net/topic/fda.md), [pfizer](https://search.noagendashow.net/topic/pfizer.md), [comirnaty](https://search.noagendashow.net/topic/comirnaty.md), [emergency use authorization](https://search.noagendashow.net/topic/emergency-use-authorization.md), legal distinction, [5g](https://search.noagendashow.net/topic/5g.md)

### FDA Approval of Pfizer Comirnaty and Liability Shields

- **Episode:** [1376: Dead Puppies](https://search.noagendashow.net/episode/1376-dead-puppies.md)
- **Published:** 2021-08-26
- **Time:** 34:41–45:17
- **Transcript:** https://search.noagendashow.net/episode/1376-dead-puppies/chapter/fda-approval-of-pfizer-comirnaty-and-liability-shields.md

The FDA's full approval of the Pfizer-BioNTech vaccine, rebranded as Comirnaty, has created confusion regarding legal liability. While Comirnaty is approved, the existing stock of Pfizer vaccines remains under Emergency Use Authorization (EUA), which maintains a liability shield for the manufacturer. Critics argue the approval process bypassed traditional advisory committee discussions to expedite mandates.

Keywords: [fda](https://search.noagendashow.net/topic/fda.md), [pfizer](https://search.noagendashow.net/topic/pfizer.md), [comirnaty](https://search.noagendashow.net/topic/comirnaty.md), [biontech](https://search.noagendashow.net/topic/biontech.md), [emergency use authorization](https://search.noagendashow.net/topic/emergency-use-authorization.md), [liability](https://search.noagendashow.net/topic/liability.md)

### Vaccine Rebranding, Comirnaty and Spikevax

- **Episode:** [1362: Shot to Win](https://search.noagendashow.net/episode/1362-shot-to-win.md)
- **Published:** 2021-07-09
- **Time:** 1:11:53–1:13:45
- **Transcript:** https://search.noagendashow.net/episode/1362-shot-to-win/chapter/vaccine-rebranding-comirnaty-and-spikevax.md

The hosts discuss the official rebranding of COVID-19 vaccines in Australia. The Pfizer-BioNTech vaccine is being marketed as "Comirnaty," while Moderna has chosen the name "Spikevax." John C. Dvorak criticizes the name Spikevax for being too literal regarding the spike protein, comparing it to a soda company renaming its product "Sugar Will Kill You."

Keywords: [pfizer](https://search.noagendashow.net/topic/pfizer.md), [moderna](https://search.noagendashow.net/topic/moderna.md), [comirnaty](https://search.noagendashow.net/topic/comirnaty.md), spikevax, [rebranding](https://search.noagendashow.net/topic/rebranding.md)

### Comirnaty Rebranding, Pfizer Marketing Dominance

- **Episode:** [1333: Vaxxhole](https://search.noagendashow.net/episode/1333-vaxxhole.md)
- **Published:** 2021-03-28
- **Time:** 1:10:49–1:14:52
- **Transcript:** https://search.noagendashow.net/episode/1333-vaxxhole/chapter/comirnaty-rebranding-pfizer-marketing-dominance.md

The Pfizer-BioNTech vaccine has been officially branded as "Comirnaty" in Europe, though it is still widely referred to by the manufacturer's name in the US. This branding strategy is compared to "Xerox" or "Kleenex," where the company name becomes synonymous with the product, solidifying Pfizer's market dominance.

Keywords: [comirnaty](https://search.noagendashow.net/topic/comirnaty.md), [pfizer](https://search.noagendashow.net/topic/pfizer.md), [biontech](https://search.noagendashow.net/topic/biontech.md), [branding](https://search.noagendashow.net/topic/branding.md), [pharmaceutical industry](https://search.noagendashow.net/topic/pharmaceutical-industry.md)

---

This is the markdown version of a page on The No Agenda Show for AI agents. Every public page on this site has one: add `.md` to its URL, or request it with `Accept: text/markdown`.

- [Site index for agents (llms.txt)](https://search.noagendashow.net/llms.txt)
- [Home](https://search.noagendashow.net/index.md)
- [Search transcripts](https://search.noagendashow.net/search.md)
- [All episodes](https://search.noagendashow.net/episodes.md)
- [Topics](https://search.noagendashow.net/topics.md)
- [People](https://search.noagendashow.net/people.md)